Freezing out cancer risk: new balloon treatment for Barrett's esophagus

NCT ID NCT03311451

Ongoing Disease control Sponsor: Merit Medical Systems, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device that freezes abnormal cells in the esophagus to treat Barrett's esophagus, a condition that can lead to cancer. About 62 adults with low- or high-grade dysplasia (precancerous changes) will receive the treatment. The goal is to see if the freezing balloon safely removes these abnormal cells and reduces the need for more invasive procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARRETT ESOPHAGUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Barrett esophagus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BARRETT ESOPHAGUS

Contacts and locations

Locations

AMC Medical Research B.V.

Amsterdam, Netherlands, Netherlands
Catharina Hospital Eindhoven

Eindhoven, Netherlands, Netherlands
Erasmus Medical Center

Rotterdam, Netherlands, Netherlands
St. Antonius Hospital

Nieuwegein, Netherlands
UMC Groningen

Groningen, Netherlands, Netherlands
UMC Utrecht

Utrecht, Netherlands, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.